Mode of interaction of G-quartets with the integrase of human immunodeficiency virus type 1.

Oligonucleotides that can form a highly stable intramolecular four-stranded DNA structure containing two stacked guanosine-quartets (G-quartets) have been reported to inhibit the replication of the human immunodeficiency virus type 1 (HIV-1) in cell culture. Two possible mechanisms for the observed antiviral activity have been proposed: interference with virus adsorption to the cell and/or inhibition of HIV-1 integrase. We investigated the molecular interaction of G-quartet-containing oligonucleotides with HIV-1 integrase in comparison with random oligonucleotides and dextran sulfate. The prototypical G-quartet-containing oligonucleotide, T30177 (Zintevir), inhibited the overall integration reaction with an IC50 value of 80 nM. A random oligonucleotide was 10-fold less potent, but dextran sulfate was more potent, with an IC50 value of 7 nM. We developed novel kinetic assays to dissect the overall integration reaction in three steps: the formation of the initial stable complex (ISC), the 3'-processing reaction, and the DNA strand-transfer step. We then analyzed the kinetics of the ISC formation and 3'-processing. The rate constant determined for the conversion of ISC into the cleaved product was 0.08 +/- 0.01 min-1. T30177 did not inhibit 3'-processing or DNA strand transfer, whereas dextran sulfate inhibited DNA strand transfer to some extent. Binding studies using surface plasmon resonance technology revealed that both T30177 and dextran sulfate were capable of preventing the binding of integrase to specific DNA. We propose a model in which the interaction of HIV-1 integrase with G-quartets results in the inhibition of the formation of the ISC between integrase and substrate DNA. Finally, we selected for an HIV-1 strain that was resistant to T30177 in cell culture. DNA sequence analysis revealed mutations in the envelope glycoprotein gp120 but not in the integrase gene. Although gp120 seems to be the main target for the antiviral activity in cell culture of G-quartets, the study of their specific inhibition of HIV-1 integrase may lead to the development of effective integrase inhibitors.

[1]  Y. Pommier,et al.  Ion selective folding of loop domains in a potent anti-HIV oligonucleotide. , 1997, Biochemistry.

[2]  Y. Pommier,et al.  Inhibition of the human immunodeficiency virus type 1 integrase by guanosine quartet structures. , 1996, Biochemistry.

[3]  Q. Jia,et al.  Inhibitors of HIV-1 replication that inhibit HIV integrase , 1996 .

[4]  Y. Pommier,et al.  Effects of nucleotide analogues on human immunodeficiency virus type 1 integrase. , 1996, Molecular pharmacology.

[5]  M. Hogan,et al.  Intramolecular G-quartet Motifs Confer Nuclease Resistance to a Potent Anti-HIV Oligonucleotide (*) , 1996, The Journal of Biological Chemistry.

[6]  H. Buc,et al.  The Metal Ion-induced Cooperative Binding of HIV-1 Integrase to DNA Exhibits a Marked Preference for Mn(II) Rather than Mg(II) (*) , 1996, The Journal of Biological Chemistry.

[7]  Y. Pommier,et al.  (-)-Arctigenin as a lead structure for inhibitors of human immunodeficiency virus type-1 integrase. , 1996, Journal of medicinal chemistry.

[8]  R A Houghten,et al.  Identification of a hexapeptide inhibitor of the human immunodeficiency virus integrase protein by using a combinatorial chemical library. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[9]  Y. Pommier,et al.  T30177, an oligonucleotide stabilized by an intramolecular guanosine octet, is a potent inhibitor of laboratory strains and clinical isolates of human immunodeficiency virus type 1 , 1995, Antimicrobial agents and chemotherapy.

[10]  Rolf Boelens,et al.  The DNA-binding domain of HIV-1 integrase has an SH3-like fold , 1995, Nature Structural Biology.

[11]  Lee Sp,et al.  Substrate-length-dependent activities of human immunodeficiency virus type 1 integrase in vitro: differential DNA binding affinities associated with different lengths of substrates. , 1995 .

[12]  Lee Sp,et al.  CHARACTERIZATION OF MG2+-DEPENDENT 3'-PROCESSING ACTIVITY FOR HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 INTEGRASE IN VITRO : REAL-TIME KINETIC STUDIES USING FLUORESCENCE RESONANCE ENERGY TRANSFER , 1995 .

[13]  A M Gronenborn,et al.  Solution structure of the DNA binding domain of HIV-1 integrase. , 1995, Biochemistry.

[14]  Erik De Clercq,et al.  Toward improved anti-HIV chemotherapy: therapeutic strategies for intervention with HIV infections. , 1995 .

[15]  P. Brown,et al.  An Essential Interaction between Distinct Domains of HIV-1 Integrase Mediates Assembly of the Active Multimer (*) , 1995, The Journal of Biological Chemistry.

[16]  M. McGrath,et al.  Suppression of Human Immunodeficiency Virus Type 1 Activity in Vitro by Oligonucleotides Which Form Intramolecular Tetrads (*) , 1995, The Journal of Biological Chemistry.

[17]  A. Engelman,et al.  Crystal structure of the catalytic domain of HIV-1 integrase: similarity to other polynucleotidyl transferases. , 1994, Science.

[18]  D. Ecker,et al.  Potent and specific inhibition of HIV envelope-mediated cell fusion and virus binding by G quartet-forming oligonucleotide (ISIS 5320). , 1994, AIDS research and human retroviruses.

[19]  J. Mouscadet,et al.  Triplex-mediated inhibition of HIV DNA integration in vitro. , 1994, The Journal of biological chemistry.

[20]  K. Kohn,et al.  Inhibition of HIV-1 integrase by flavones, caffeic acid phenethyl ester (CAPE) and related compounds. , 1994, Biochemical pharmacology.

[21]  P. Brown,et al.  A stable complex between integrase and viral DNA ends mediates human immunodeficiency virus integration in vitro. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[22]  Y. Pommier,et al.  Inhibition of human immunodeficiency virus type 1 integrase by 3'-azido-3'-deoxythymidylate. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[23]  R. Plasterk,et al.  A high-throughput, non-radioactive microtiter plate assay for activity of the human immunodeficiency virus integrase protein. , 1994, Nucleic acids research.

[24]  D. Hazuda,et al.  A novel assay for the DNA strand-transfer reaction of HIV-1 integrase. , 1994, Nucleic acids research.

[25]  R. Plasterk,et al.  Activities of the feline immunodeficiency virus integrase protein produced in Escherichia coli , 1994, Journal of virology.

[26]  D. Ecker,et al.  Combinatorially selected guanosine-quartet structure is a potent inhibitor of human immunodeficiency virus envelope-mediated cell fusion. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[27]  A. Skalka,et al.  Rapid solution assays for retroviral integration reactions and their use in kinetic analyses of wild-type and mutant Rous sarcoma virus integrases. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[28]  F. Bushman,et al.  Identification of discrete functional domains of HIV‐1 integrase and their organization within an active multimeric complex. , 1993, The EMBO journal.

[29]  R. Plasterk,et al.  Complementation between HIV integrase proteins mutated in different domains. , 1993, The EMBO journal.

[30]  K. Kohn,et al.  Inhibitors of human immunodeficiency virus integrase. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[31]  S. Ueda,et al.  Integration is essential for efficient gene expression of human immunodeficiency virus type 1 , 1993, Journal of virology.

[32]  W. Schleif,et al.  Requirement of active human immunodeficiency virus type 1 integrase enzyme for productive infection of human T-lymphoid cells , 1992, Journal of virology.

[33]  P. Brown,et al.  Reversal of integration and DNA splicing mediated by integrase of human immunodeficiency virus. , 1992, Science.

[34]  F. Bushman,et al.  Activities of human immunodeficiency virus (HIV) integration protein in vitro: specific cleavage and integration of HIV DNA. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[35]  P. Brown,et al.  Correct integration of retroviral DNA in vitro , 1987, Cell.

[36]  Broder,et al.  Phosphorylation of 3'-azido-3'-deoxythymidine and selective interaction of the 5'-triphosphate with human immunodeficiency virus reverse transcriptase. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[37]  E. De Clercq,et al.  Toward improved anti-HIV chemotherapy: therapeutic strategies for intervention with HIV infections. , 1995, Journal of medicinal chemistry.

[38]  A. Skalka,et al.  The retroviral enzymes. , 1994, Annual review of biochemistry.